NKF advises BioTelemetry on LifeWatch offer

Niederer Kraft & Frey (NKF) is advising BioTelemetry, Inc. on the public tender offer made by its subsidiary Cardiac Monitoring Holding Company, LLC for all publicly-held registered shares of LifeWatch AG. The transaction is a recommended competing bid in which LifeWatch shareholders are offered cash and shares of BioTelemetry common stock, with a total transaction value of approximately CHF260m.

The NKF team is led by Philipp Haas (partner) and Thomas Brönnimann (partner) and further consisted of Deirdre Ni Annrachain (associate), Julia Tolstova (associate), Samuel Hochstrasser (associate) and Alexander Göbel (junior associate, all corporate/M&A).

NKF acted alongside Greenberg Traurig, LLP, who acts as US counsel to BioTelemetry.